WiseGuyReports.com adds“Biosimulation 2016 World Market Research,Adoption
and Industrial Overview Report Forecasting to 2022”reports to its database.
COMPLETE
REPORT DETAILS @
https://www.wiseguyreports.com/reports/world-biosimulation-market-opportunities-and-forecasts-2014-2022
Biosimulation refers to simulation of biological
processes by means of computer program. Biosimulation technology has wide
application in drug discovery and development. It is a predictive tool and used
in discovery stage to determine the future outcomes of current experimental
trials. The report provides in-depth analysis of the different segments for
global biosimulation market and comprehensively determines the market drivers,
major constraints and potential opportunities. Pin-point analysis of leading
company profiles and their strategies would be helpful to professionals to gain
the competitive intelligence. Complete assessment of past and current market
trends would be helpful for future projections.
Drug discovery process involves huge investment and
failure of drug molecule in the late phase, results in wastage of efforts and
money. Hence, there is necessity to develop a tool that will outlay the future
drug molecule during discovery phase. This is the prime reason that drives the
growth of global biosimulation market. Further, the growth is supported by high
healthcare expenditure, advanced software programs and improved simulation
technology. Limited knowledge of biological processes, lack of standard methods
for biosimulation and high risk of failure of drugs in biosimulation are the
major restrains for global biosimulation market. However, increasing accuracy
of the technique and integration with other methods for better predictions
would be helpful to minimize these restrains.
For more information or any query mail at
sales@wiseguyreports.com
Global Biosimulation Market by ApplicationThe global biosimulation market
has two broad application categories, namely drug discovery and drug
development. Applications in drug discovery includes Lead identification, Lead
optimization, Target identification, Target validation; whereas, applications
in drug development include, Preclinical testing and clinical trials and
Patient validation. Application of pharmacokinetic/pharmacodynamic model (PKPD)
in pre-clinical testing would be the most opportunistic area for the growth of
drug discovery and drug development process.
Global Biosimulation Market by GeographyGeographically, global biosimulation
market is segmented into North America, Europe, Asia and LAMEA. North America
commands the global biosimulation market and holds more than half of the share
value as compared to total global sale. This growth in North America is
significantly driven by off patenting of many drugs and search for new drug
moiety. Europe stands next to North America for global biosimulation market
where growth is majorly driven by government initiatives. Asia-pacific is
emerging market where the growth is driven by increase in number of CRO’s.
Competitive LandscapeGlobal biosimulation market is highly competitive,
which is dominated by few big players; whereas, rest of the market is highly
fragmented. The leading companies in global biosimulation market include Accelrys
inc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata
and Insilico BioTechnology. Companies are focusing on the strategy of
collaborations and partnerships to aid the innovation. Accelrys Inc. has signed
a three-year agreement with Pfizer for the use of its modeling and simulation
software by Pfizer’s researchers worldwide.
High Level AnalysisMarket dynamics are focused with market drivers,
challenges and opportunities, which would be helpful to understand market
behavior. Competitive landscape section explicitly covers key players,
collaborations, partnerships and agreements, and it would prove beneficial to
understand the niche market trends. Porter’s five forces analysis have been
used to determine the attractiveness of global biosimulation market. Bargaining
power of supplier is high as there is less or no threat of backward integration
by buyers. Biosimulation technology reduces the total cost of drug discovery
and development for pharmaceutical manufacturers. Hence, there is high demand
for simulation software and buyers group is less concentrated, which would be
sufficient to decrease the buyers bargaining power. Biosimulation techniques
need understanding of biological processes and systems, and it also requires
standardization of simulation methodology. Lack of expertise in this field puts
the threat from substitute and new entrants on low risk situation.
REQUEST
FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-biosimulation-market-opportunities-and-forecasts-2014-2022
KEY
BENEFITS
This report offers the following benefits in particular:
Broad coverage of global biosimulation market including drivers, restrains and opportunities would assist professionals to understand the market behavior
Comprehensive analysis of different segments helps to recognize and exploit future opportunities within global biosimulation market
Competitive Landscape section offers profound assessment of leading company portfolios, technological advances, collaborations and partnerships, which would be informative to professionals in corporate sector
Porter’s five forces tool provides in-depth analysis of current market trends, which would be beneficial in strategic decision making
KEY DELIVERABLESThe global biosimulation market is segmented into two major categories such as application and geography.
Broad coverage of global biosimulation market including drivers, restrains and opportunities would assist professionals to understand the market behavior
Comprehensive analysis of different segments helps to recognize and exploit future opportunities within global biosimulation market
Competitive Landscape section offers profound assessment of leading company portfolios, technological advances, collaborations and partnerships, which would be informative to professionals in corporate sector
Porter’s five forces tool provides in-depth analysis of current market trends, which would be beneficial in strategic decision making
KEY DELIVERABLESThe global biosimulation market is segmented into two major categories such as application and geography.
MARKET
BY APPLICATION
Drug Discovery
Lead Identification
Lead Optimization
Target Identification
Target Validation
Drug Development
Preclinical Testing and Clinical Trials
In Patient Validation
MARKET BY GEOGRAPHY
Lead Identification
Lead Optimization
Target Identification
Target Validation
Drug Development
Preclinical Testing and Clinical Trials
In Patient Validation
MARKET BY GEOGRAPHY
North America
Europe
Asia-Pacific
LAMEA
Europe
Asia-Pacific
LAMEA
CONTINUE…….
For more information or any query mail at
sales@wiseguyreports.com
Contact
Us:
NORAH TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph:
+44 208 133 9349 (UK)
No comments:
Post a Comment